Clinical trial
Lidorestat (IDD 676) for the Treatment of Diabetic Neuropathy
NCT00043797 · The Institute for Diabetes Discovery, LLC, Industry · Unknown status
Key facts
| NCT number | NCT00043797 |
|---|---|
| Title | Lidorestat (IDD 676) for the Treatment of Diabetic Neuropathy |
| Lead sponsor | The Institute for Diabetes Discovery, LLC, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetic Polyneuropathy |
| Intervention type | Drug |
| Interventions | Lidorestat (IDD 676) |
| First posted | Aug 15, 2002 |
| Last update posted | Jun 24, 2005 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: